Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Bloomberg
Wednesday, October 27, 2010 - 11:50am
tags:
Amgen, Prolia, UK, NHS
King Pharma Sales Rep Sues For Overtime Pay
Pharmalot
Wednesday, October 27, 2010 - 11:48am
tags:
overtime lawsuits, drug reps, King
Earnings Preview: Merck to report 3Q results
Yahoo/AP
Wednesday, October 27, 2010 - 11:43am
tags:
earnings, Merck
MacroGenics, Pfizer sign collaboration deal
Yahoo/AP
Wednesday, October 27, 2010 - 11:43am
tags:
Pfizer, Macrogenics, cancer
Myriad joins Abbott Labs' breast cancer study
Yahoo/AP
Wednesday, October 27, 2010 - 11:41am
tags:
Myriad, Abbott Laboratories, breast cancer
Provectus Gains Momentum Ahead of Upcoming Melanoma Data Presentation
Seeking Alpha
Wednesday, October 27, 2010 - 11:31am
tags:
Provectus, melanoma, oncology, dermatology
Novo Nordisk Third-Quarter Profit Beats Analyst Estimates; Forecast Raised
Bloomberg
Wednesday, October 27, 2010 - 9:17am
tags:
earnings, Novo Nordisk
Next For Arena: Layoffs, Approval, Or Both?
Forbes
Wednesday, October 27, 2010 - 9:05am
tags:
Arena Pharmaceuticals, layoffs, FDA
In Sanofi-Genzyme Deal, Both Sides Are Dancing Around Bad Information
BNET Pharma
Wednesday, October 27, 2010 - 9:02am
tags:
M&A, Sanofi, Genzyme
Elan Posts Third-Quarter Loss After Year-Earlier Profit on J&J
Bloomberg
Wednesday, October 27, 2010 - 9:01am
tags:
Elan, JNJ, earnings
Glaxo to Pay $750 Million for Sale of Bad Products
NY Times, NY
Wednesday, October 27, 2010 - 9:01am
tags:
GSK, drug manufacturing, whistleblowers, Paxil, Avandia, Coreg, Tagamet
The Changing Landscape of Pharmaceutical Information
Motley Fool
Tuesday, October 26, 2010 - 3:22pm
tags:
social media, electronic medical records
Thank Goodness for Amgen's New Kids
Motley Fool
Tuesday, October 26, 2010 - 3:20pm
tags:
Amgen, Prolia
From Gross to Net at Gilead Sciences
Motley Fool
Tuesday, October 26, 2010 - 12:38pm
tags:
Gilead Sciences
Long Odds Seen For Diet Drugs
WSJ Online
Tuesday, October 26, 2010 - 12:37pm
tags:
obesity, Arena Pharmaceuticals, Eisai, Orexigen, Contrave
Amylin Pharmaceuticals: Will it Navigate the Rough Waters Ahead?
Seeking Alpha
Tuesday, October 26, 2010 - 11:54am
tags:
Amylin, diabetes, exanitide
Bayer rival Boehringer prices blood pill at $6.75
Reuters
Tuesday, October 26, 2010 - 11:52am
tags:
Bayer, Boehringer Ingelheim, drug pricing, anticlotting, JNJ, Pradaxa
Should Investors Take A Chance On Savient?
Investopedia
Tuesday, October 26, 2010 - 11:50am
tags:
Savient, Krystexxa, Bristol-Myers Squibb, Forest Labs, Merck, Novartis, PDI Pharma, Pfizer
GlaxoSmithKline's Dividends May Not Last Forever
Motley Fool
Tuesday, October 26, 2010 - 11:48am
tags:
GSK
Abbott Sues Anchen for Infringing U.S. Patent of Its Zemplar Kidney Drug
Bloomberg
Tuesday, October 26, 2010 - 11:23am
tags:
Abbott Laboratories, patents, Zemplar, Anchen, kidney disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.